Biophan’s Myo-Vad Could Be Ideal For Battlefield, Bridge To Therapy
This article was originally published in The Gray Sheet
A cardiac support device simple enough to install on the battlefield could be available in three years, according to Biophan CEO Mike Weiner
You may also be interested in...
A research partnership between Biophan Technologies and FDA aims to make it safer for patients with implanted medical devices to undergo magnetic resonance imaging (MRI) procedures
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.